These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 8891141)
1. In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides. Vidalin O; Major ME; Rayner B; Imbach JL; Trépo C; Inchauspé G Antimicrob Agents Chemother; 1996 Oct; 40(10):2337-44. PubMed ID: 8891141 [TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence. Wakita T; Wands JR J Biol Chem; 1994 May; 269(19):14205-10. PubMed ID: 8188703 [TBL] [Abstract][Full Text] [Related]
3. Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation. Alt M; Eisenhardt S; Serwe M; Renz R; Engels JW; Caselmann WH Eur J Clin Invest; 1999 Oct; 29(10):868-76. PubMed ID: 10583429 [TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273 [TBL] [Abstract][Full Text] [Related]
5. Characterization of ribonuclease H activities present in two cell-free protein synthesizing systems, the wheat germ extract and the rabbit reticulocyte lysate. Cazenave C; Frank P; Büsen W Biochimie; 1993; 75(1-2):113-22. PubMed ID: 8389210 [TBL] [Abstract][Full Text] [Related]
6. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay. Seki M; Honda Y J Biochem; 1995 Dec; 118(6):1199-204. PubMed ID: 8720135 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides. Brown-Driver V; Eto T; Lesnik E; Anderson KP; Hanecak RC Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):145-54. PubMed ID: 10355821 [TBL] [Abstract][Full Text] [Related]
8. Targeting of antisense DNA: comparison of activity of anti-rabbit beta-globin oligodeoxyribonucleoside phosphorothioates with computer predictions of mRNA folding. Jaroszewski JW; Syi JL; Ghosh M; Ghosh K; Cohen JS Antisense Res Dev; 1993; 3(4):339-48. PubMed ID: 8155975 [TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. Hanecak R; Brown-Driver V; Fox MC; Azad RF; Furusako S; Nozaki C; Ford C; Sasmor H; Anderson KP J Virol; 1996 Aug; 70(8):5203-12. PubMed ID: 8764029 [TBL] [Abstract][Full Text] [Related]
10. Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation. Alt M; Renz R; Hofschneider PH; Caselmann WH Arch Virol; 1997; 142(3):589-99. PubMed ID: 9349305 [TBL] [Abstract][Full Text] [Related]
12. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression. Fukuma T; Walton CM; Wu CH; Wu GY Bioconjug Chem; 2003; 14(2):295-301. PubMed ID: 12643739 [TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide inhibition of bovine leukemia virus tax expression in a cell-free system. Cantor GH; Palmer GH Antisense Res Dev; 1992; 2(2):147-52. PubMed ID: 1327333 [TBL] [Abstract][Full Text] [Related]
14. Biologic activity of oligonucleotides with polarity and anomeric center reversal. Tan TM; Kalisch BW; van de Sande JH; Ting RC; Tan YH Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):95-101. PubMed ID: 9593047 [TBL] [Abstract][Full Text] [Related]
15. RNase H-mediated inhibition of translation by antisense oligodeoxyribonucleotides: use of backbone modification to improve specificity. Larrouy B; Blonski C; Boiziau C; Stuer M; Moreau S; Shire D; Toulmé JJ Gene; 1992 Nov; 121(2):189-94. PubMed ID: 1332911 [TBL] [Abstract][Full Text] [Related]
16. Oligodeoxynucleotide analogs as informational drugs to regulate translation. Ghosh M; Ghosh K; Cohen JS Nucleic Acids Symp Ser; 1991; (24):139-42. PubMed ID: 1668685 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism. Boiziau C; Kurfurst R; Cazenave C; Roig V; Thuong NT; Toulmé JJ Nucleic Acids Res; 1991 Mar; 19(5):1113-9. PubMed ID: 1850511 [TBL] [Abstract][Full Text] [Related]
18. Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression. Wakita T; Moradpour D; Tokushihge K; Wands JR J Med Virol; 1999 Mar; 57(3):217-22. PubMed ID: 10022790 [TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of delta antigen by in vitro system by antisense oligodeoxynucleotide: implications for translation mechanism and treatment. Chen TZ; Wu JC; Au LC; Choo KB J Virol Methods; 1997 May; 65(2):183-9. PubMed ID: 9186941 [TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation. Tallet-Lopez B; Aldaz-Carroll L; Chabas S; Dausse E; Staedel C; Toulmé JJ Nucleic Acids Res; 2003 Jan; 31(2):734-42. PubMed ID: 12527783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]